Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. UTMD
UTMD logo

UTMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Utah Medical Products Inc (UTMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
69.240
1 Day change
-1.40%
52 Week Range
71.810
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Utah Medical Products Inc (UTMD) is not a strong buy at the moment for a beginner investor with a long-term strategy. While technical indicators show bullish momentum, the overbought RSI and lack of positive catalysts, combined with declining financial performance, suggest caution. The stock may not align with the user's preference for long-term growth opportunities.

Technical Analysis

The stock shows bullish momentum with MACD positively expanding and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). However, RSI at 85.854 indicates an overbought condition, suggesting a potential pullback. Key resistance levels are R1: 68.689 and R2: 70.466, with support at S1: 62.936 and S2: 61.159.

Positive Catalysts

  • Bullish technical indicators such as MACD and moving averages. Gross margin slightly improved YoY.

Neutral/Negative Catalysts

  • RSI indicates overbought conditions. Financial performance shows YoY declines in revenue (-1.23%), net income (-11.58%), and EPS (-6.98%). No recent news or significant trading trends. Stock trend analysis predicts a potential decline in the short term (-0.52% next day, -1.14% next week, -2.24% next month).

Financial Performance

In Q4 2025, revenue dropped to $9,045,000 (-1.23% YoY), net income fell to $2,566,000 (-11.58% YoY), and EPS declined to 0.8 (-6.98% YoY). Gross margin slightly increased to 58.2% (+0.14% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target updates available.

Wall Street analysts forecast UTMD stock price to rise
Analyst Rating
0
Wall Street analysts forecast UTMD stock price to rise
Buy
Hold
Sell
0
Current: 70.220
sliders
Low
0
Averages
0
High
0
0
Current: 70.220
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch